JR Pharma Engineering ApS — Credit Rating and Financial Key Figures

JR Pharma Engineering ApS (CVR number: 42398993) is a company from GENTOFTE. The company reported a net sales of 2 mDKK in 2023, demonstrating a growth of 5.1 % compared to the previous year. The operating profit percentage was at 43 % (EBIT: 0.8 mDKK), while net earnings were 650.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 72.6 %, which can be considered excellent and Return on Equity (ROE) was 94.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 63.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. JR Pharma Engineering ApS's liquidity measured by quick ratio was 2.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.